GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (FRA:THR) » Definitions » Book Value per Share

ThermoGenesis Holdings (FRA:THR) Book Value per Share : €0.29 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is ThermoGenesis Holdings Book Value per Share?

ThermoGenesis Holdings's book value per share for the quarter that ended in Mar. 2024 was €0.29.

During the past 12 months, ThermoGenesis Holdings's average Book Value Per Share Growth Rate was -111.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ThermoGenesis Holdings was 41.70% per year. The lowest was -89.20% per year. And the median was -4.00% per year.

ThermoGenesis Holdings's current price is €1.62. Its book value per share for the quarter that ended in Mar. 2024 was €0.29. Hence, today's PB Ratio of ThermoGenesis Holdings is 5.66.

During the past 13 years, the highest P/B Ratio of ThermoGenesis Holdings was 37.60. The lowest was 0.15. And the median was 1.05.


ThermoGenesis Holdings Book Value per Share Historical Data

The historical data trend for ThermoGenesis Holdings's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ThermoGenesis Holdings Book Value per Share Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.49 24.01 12.80 3.91 -1.47

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.70 1.43 1.37 -0.49 0.29

Competitive Comparison of ThermoGenesis Holdings's Book Value per Share

For the Medical Devices subindustry, ThermoGenesis Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's PB Ratio falls into.



ThermoGenesis Holdings Book Value per Share Calculation

ThermoGenesis Holdings's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-1.53-0.00)/1.04
=-1.47

ThermoGenesis Holdings's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.90-0.00)/3.14
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


ThermoGenesis Holdings  (FRA:THR) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


ThermoGenesis Holdings Book Value per Share Related Terms

Thank you for viewing the detailed overview of ThermoGenesis Holdings's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ThermoGenesis Holdings (FRA:THR) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.